1. Home
  2. News
  3. Supha Pharmachem Ltd
  4. Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
More Supha Pharmachem Ltd news
Supha Pharmachem LtdBSE: SUPHA

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Apr 16, 2025 at 9:20 AM EDT · Issued by Supha Pharmachem Ltd via BSE India

Filed with BSE · Apr 16, 2025 at 9:20 AM EDT

On 6ix: 6ix.com/news/announcement-under-regulation-30-lodr-analyst-investor-meet-intimation-215

Analysts/Institutional Investor Meet/Con. Call Updates

View Attachment

6ix hasn’t read this filing yet.

View original source (BSE India)Supha Pharmachem Ltd on 6ix

Earlier from Supha Pharmachem

  • Supha Pharmachem Ltd Press Release Apr 08 2025Apr 8, 2025
  • Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 8, 2025
  • Supha Pharmachem Ltd Press Release Apr 07 2025Apr 7, 2025
  • Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Apr 7, 2025
  • Corporate Action-Fixes Record Date For Rights IssueApr 7, 2025

Later from Supha Pharmachem

  • Supha Pharmachem Ltd Press Release Apr 21 2025Apr 21, 2025
  • Supha Pharmachem Ltd Press Release Apr 22 2025Apr 22, 2025
  • Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Remedium Lifecare Limited Held On 24Th April, 2025Apr 24, 2025
  • Supha Pharmachem Ltd Press Release Apr 24 2025Apr 24, 2025
  • Format of the Initial Disclosure to be made by an entity identified as a Large Corporate: Annexure AApr 26, 2025
All Supha Pharmachem news releases↗

Follow Supha Pharmachem into a list and get an email when it puts out news.

Follow Supha Pharmachem
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer